AP3

Serial Number 98851818
661

Registration Progress

Application Filed
Nov 13, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AP3

Basic Information

Serial Number
98851818
Filing Date
November 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Jul 7, 2025
Application
Pending
Classes
042 044

Rights Holder

Acrivon Therapeutics, Inc.

03
Address
480 Arsenal Way, Suite 100
Watertown, MA 02472

Ownership History

Acrivon Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Legal Representation

Attorney
Sara M. Bauer

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jul 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 7, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 9, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 9, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2025 LOPE O LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN Loading...
Jun 8, 2025 LOPT I LETTER OF PROTEST EVIDENCE FORWARDED Loading...
May 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 9, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 9, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
scientific research; medical research; proteomics and biomarker discovery services, namely, medical testing services and information in the field of disease classification; scientific research and development in the fields of pharmaceuticals, therapeutics, and drug formulation and delivery; scientific research and development in the fields of proteomics and biomarker discovery; consultancy services in the field of pharmaceutical research and development services; consultancy services in the fields of medical and scientific research concerning proteomics and biomarker discovery; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to prediction of drug treatment efficacy; conducting scientific studies in the fields of proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder identification; proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder identification; providing information in the field of medical, scientific and pharmaceutical research about proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder indication services; scientific and technological research and consultation services, namely, in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, patient responder identification, indication finding, and rational drug design; drug discovery services in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers, drug repurposing, and rational drug design through optimal pathway effects in intact cells; consultancy in the field of pharmaceutical research and development services in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers, drug repurposing, indication finding, and rational drug design through pathway-based SAR
Class 044
Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, consultancy and advisory services; individual medical counseling services provided to patients; providing a website featuring information in the field of precision medicine; providing medical information to medical professionals in the form of reports in the field of precision medicine; proteomics and biomarker discoery services, namely, medical diagnostic services

Additional Information

Pseudo Mark
AP THREE

Classification

International Classes
042 044